nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—CYP1A2—Citalopram—alcohol dependence	0.133	1	CbGbCtD
Nabumetone—MPO—saliva—alcohol dependence	0.0221	0.216	CbGeAlD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00712	0.0454	CbGpPWpGaD
Nabumetone—Duodenal ulcer—Citalopram—alcohol dependence	0.00658	0.0108	CcSEcCtD
Nabumetone—PTGS1—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00658	0.042	CbGpPWpGaD
Nabumetone—Erectile dysfunction—Disulfiram—alcohol dependence	0.00622	0.0102	CcSEcCtD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0059	0.0376	CbGpPWpGaD
Nabumetone—Rectal haemorrhage—Acamprosate—alcohol dependence	0.00587	0.00966	CcSEcCtD
Nabumetone—Jaundice—Disulfiram—alcohol dependence	0.00587	0.00966	CcSEcCtD
Nabumetone—Hyperuricaemia—Acamprosate—alcohol dependence	0.00572	0.00941	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00569	0.0363	CbGpPWpGaD
Nabumetone—Gastric ulcer—Citalopram—alcohol dependence	0.00547	0.009	CcSEcCtD
Nabumetone—Blood uric acid increased—Acamprosate—alcohol dependence	0.0054	0.00889	CcSEcCtD
Nabumetone—MPO—forebrain—alcohol dependence	0.00526	0.0514	CbGeAlD
Nabumetone—PTGS2—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00522	0.0333	CbGpPWpGaD
Nabumetone—Eructation—Acamprosate—alcohol dependence	0.00521	0.00857	CcSEcCtD
Nabumetone—Melaena—Acamprosate—alcohol dependence	0.00518	0.00852	CcSEcCtD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00502	0.032	CbGpPWpGaD
Nabumetone—Calculus of kidney—Citalopram—alcohol dependence	0.00485	0.00798	CcSEcCtD
Nabumetone—Nightmare—Naltrexone—alcohol dependence	0.00485	0.00797	CcSEcCtD
Nabumetone—Abnormal vision—Acamprosate—alcohol dependence	0.00463	0.00761	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00446	0.0285	CbGpPWpGaD
Nabumetone—MPO—cardiovascular system—alcohol dependence	0.00445	0.0435	CbGeAlD
Nabumetone—Thrombophlebitis—Acamprosate—alcohol dependence	0.00445	0.00732	CcSEcCtD
Nabumetone—Gastroenteritis—Acamprosate—alcohol dependence	0.00435	0.00715	CcSEcCtD
Nabumetone—MPO—pancreas—alcohol dependence	0.00433	0.0423	CbGeAlD
Nabumetone—Vaginal haemorrhage—Citalopram—alcohol dependence	0.0043	0.00707	CcSEcCtD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00426	0.0272	CbGpPWpGaD
Nabumetone—Gastroenteritis—Naltrexone—alcohol dependence	0.00411	0.00676	CcSEcCtD
Nabumetone—Increased appetite—Acamprosate—alcohol dependence	0.0041	0.00674	CcSEcCtD
Nabumetone—Gingivitis—Citalopram—alcohol dependence	0.00405	0.00666	CcSEcCtD
Nabumetone—Dermatitis bullous—Acamprosate—alcohol dependence	0.00403	0.00663	CcSEcCtD
Nabumetone—Nephrolithiasis—Citalopram—alcohol dependence	0.00396	0.00651	CcSEcCtD
Nabumetone—Increased appetite—Naltrexone—alcohol dependence	0.00388	0.00638	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00385	0.00633	CcSEcCtD
Nabumetone—Acne—Citalopram—alcohol dependence	0.00378	0.00622	CcSEcCtD
Nabumetone—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00375	0.0239	CbGpPWpGaD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00374	0.0239	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0037	0.0236	CbGpPWpGaD
Nabumetone—MPO—digestive system—alcohol dependence	0.00369	0.0361	CbGeAlD
Nabumetone—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00364	0.00599	CcSEcCtD
Nabumetone—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00356	0.0227	CbGpPWpGaD
Nabumetone—Liver function test abnormal—Acamprosate—alcohol dependence	0.00356	0.00585	CcSEcCtD
Nabumetone—Rectal haemorrhage—Citalopram—alcohol dependence	0.00352	0.00579	CcSEcCtD
Nabumetone—MPO—blood—alcohol dependence	0.00352	0.0344	CbGeAlD
Nabumetone—Glossitis—Citalopram—alcohol dependence	0.00345	0.00568	CcSEcCtD
Nabumetone—Paraesthesia—Disulfiram—alcohol dependence	0.00345	0.00567	CcSEcCtD
Nabumetone—Somnolence—Disulfiram—alcohol dependence	0.00342	0.00562	CcSEcCtD
Nabumetone—Gastritis—Acamprosate—alcohol dependence	0.00341	0.00561	CcSEcCtD
Nabumetone—Dysphagia—Acamprosate—alcohol dependence	0.00333	0.00547	CcSEcCtD
Nabumetone—Asthma—Acamprosate—alcohol dependence	0.00333	0.00547	CcSEcCtD
Nabumetone—Fatigue—Disulfiram—alcohol dependence	0.00331	0.00545	CcSEcCtD
Nabumetone—Pancreatitis—Acamprosate—alcohol dependence	0.00326	0.00537	CcSEcCtD
Nabumetone—Angina pectoris—Acamprosate—alcohol dependence	0.00324	0.00533	CcSEcCtD
Nabumetone—Blood uric acid increased—Citalopram—alcohol dependence	0.00324	0.00533	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00314	0.0201	CbGpPWpGaD
Nabumetone—Eructation—Citalopram—alcohol dependence	0.00313	0.00514	CcSEcCtD
Nabumetone—PTGS1—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00311	0.0199	CbGpPWpGaD
Nabumetone—Melaena—Citalopram—alcohol dependence	0.00311	0.00511	CcSEcCtD
Nabumetone—Nightmare—Citalopram—alcohol dependence	0.00307	0.00505	CcSEcCtD
Nabumetone—Sweating increased—Naltrexone—alcohol dependence	0.00307	0.00505	CcSEcCtD
Nabumetone—Angina pectoris—Naltrexone—alcohol dependence	0.00307	0.00505	CcSEcCtD
Nabumetone—Erectile dysfunction—Acamprosate—alcohol dependence	0.00307	0.00504	CcSEcCtD
Nabumetone—MPO—endocrine gland—alcohol dependence	0.00305	0.0298	CbGeAlD
Nabumetone—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00304	0.005	CcSEcCtD
Nabumetone—Weight increased—Acamprosate—alcohol dependence	0.00303	0.00498	CcSEcCtD
Nabumetone—Weight decreased—Acamprosate—alcohol dependence	0.00301	0.00495	CcSEcCtD
Nabumetone—Hyperglycaemia—Acamprosate—alcohol dependence	0.003	0.00494	CcSEcCtD
Nabumetone—Aplastic anaemia—Citalopram—alcohol dependence	0.00299	0.00491	CcSEcCtD
Nabumetone—Pneumonia—Acamprosate—alcohol dependence	0.00299	0.00491	CcSEcCtD
Nabumetone—Depression—Acamprosate—alcohol dependence	0.00296	0.00487	CcSEcCtD
Nabumetone—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00293	0.00481	CcSEcCtD
Nabumetone—MPO—testis—alcohol dependence	0.00291	0.0284	CbGeAlD
Nabumetone—Myocardial infarction—Acamprosate—alcohol dependence	0.00291	0.00478	CcSEcCtD
Nabumetone—Stomatitis—Acamprosate—alcohol dependence	0.00289	0.00476	CcSEcCtD
Nabumetone—Weight increased—Naltrexone—alcohol dependence	0.00287	0.00471	CcSEcCtD
Nabumetone—MPO—nervous system—alcohol dependence	0.00286	0.0279	CbGeAlD
Nabumetone—Weight decreased—Naltrexone—alcohol dependence	0.00285	0.00469	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00284	0.0181	CbGpPWpGaD
Nabumetone—Haematuria—Acamprosate—alcohol dependence	0.00283	0.00465	CcSEcCtD
Nabumetone—Pneumonia—Naltrexone—alcohol dependence	0.00282	0.00464	CcSEcCtD
Nabumetone—Depression—Naltrexone—alcohol dependence	0.0028	0.0046	CcSEcCtD
Nabumetone—Abnormal vision—Citalopram—alcohol dependence	0.00277	0.00456	CcSEcCtD
Nabumetone—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00277	0.00455	CcSEcCtD
Nabumetone—Asthenia—Disulfiram—alcohol dependence	0.00276	0.00453	CcSEcCtD
Nabumetone—Myocardial infarction—Naltrexone—alcohol dependence	0.00275	0.00453	CcSEcCtD
Nabumetone—MPO—liver—alcohol dependence	0.00275	0.0269	CbGeAlD
Nabumetone—MPO—central nervous system—alcohol dependence	0.00275	0.0269	CbGeAlD
Nabumetone—MPO—Selenium Micronutrient Network—GGT1—alcohol dependence	0.00269	0.0172	CbGpPWpGaD
Nabumetone—Haemoglobin—Acamprosate—alcohol dependence	0.00268	0.0044	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00267	0.0171	CbGpPWpGaD
Nabumetone—Haemorrhage—Acamprosate—alcohol dependence	0.00266	0.00438	CcSEcCtD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00263	0.0168	CbGpPWpGaD
Nabumetone—Gastroenteritis—Citalopram—alcohol dependence	0.00261	0.00428	CcSEcCtD
Nabumetone—Hepatic failure—Citalopram—alcohol dependence	0.00257	0.00423	CcSEcCtD
Nabumetone—Visual impairment—Acamprosate—alcohol dependence	0.00257	0.00422	CcSEcCtD
Nabumetone—Dizziness—Disulfiram—alcohol dependence	0.00254	0.00418	CcSEcCtD
Nabumetone—PTGS1—forebrain—alcohol dependence	0.0025	0.0244	CbGeAlD
Nabumetone—Tinnitus—Acamprosate—alcohol dependence	0.00248	0.00409	CcSEcCtD
Nabumetone—PTGS2—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00247	0.0158	CbGpPWpGaD
Nabumetone—Increased appetite—Citalopram—alcohol dependence	0.00246	0.00404	CcSEcCtD
Nabumetone—Rash—Disulfiram—alcohol dependence	0.00242	0.00398	CcSEcCtD
Nabumetone—Dermatitis bullous—Citalopram—alcohol dependence	0.00242	0.00397	CcSEcCtD
Nabumetone—Headache—Disulfiram—alcohol dependence	0.00241	0.00396	CcSEcCtD
Nabumetone—Chills—Acamprosate—alcohol dependence	0.00239	0.00393	CcSEcCtD
Nabumetone—PTGS2—forebrain—alcohol dependence	0.00239	0.0233	CbGeAlD
Nabumetone—PTGS1—Biological oxidations—ADH6—alcohol dependence	0.00237	0.0151	CbGpPWpGaD
Nabumetone—Alopecia—Acamprosate—alcohol dependence	0.00235	0.00387	CcSEcCtD
Nabumetone—Tinnitus—Naltrexone—alcohol dependence	0.00235	0.00387	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00234	0.015	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00233	0.0149	CbGpPWpGaD
Nabumetone—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00231	0.0038	CcSEcCtD
Nabumetone—Flatulence—Acamprosate—alcohol dependence	0.00229	0.00376	CcSEcCtD
Nabumetone—Tension—Acamprosate—alcohol dependence	0.00228	0.00374	CcSEcCtD
Nabumetone—Chills—Naltrexone—alcohol dependence	0.00226	0.00372	CcSEcCtD
Nabumetone—Nervousness—Acamprosate—alcohol dependence	0.00225	0.0037	CcSEcCtD
Nabumetone—Alopecia—Naltrexone—alcohol dependence	0.00223	0.00366	CcSEcCtD
Nabumetone—PTGS2—adrenal cortex—alcohol dependence	0.00221	0.0216	CbGeAlD
Nabumetone—MPO—brain—alcohol dependence	0.00218	0.0213	CbGeAlD
Nabumetone—Tremor—Acamprosate—alcohol dependence	0.00217	0.00357	CcSEcCtD
Nabumetone—Flatulence—Naltrexone—alcohol dependence	0.00216	0.00356	CcSEcCtD
Nabumetone—Tension—Naltrexone—alcohol dependence	0.00215	0.00354	CcSEcCtD
Nabumetone—Ill-defined disorder—Acamprosate—alcohol dependence	0.00215	0.00354	CcSEcCtD
Nabumetone—Anaemia—Acamprosate—alcohol dependence	0.00214	0.00353	CcSEcCtD
Nabumetone—Liver function test abnormal—Citalopram—alcohol dependence	0.00213	0.00351	CcSEcCtD
Nabumetone—Agitation—Acamprosate—alcohol dependence	0.00213	0.00351	CcSEcCtD
Nabumetone—Nervousness—Naltrexone—alcohol dependence	0.00213	0.00351	CcSEcCtD
Nabumetone—Angioedema—Acamprosate—alcohol dependence	0.00212	0.00349	CcSEcCtD
Nabumetone—PTGS1—cardiovascular system—alcohol dependence	0.00211	0.0206	CbGeAlD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00211	0.0134	CbGpPWpGaD
Nabumetone—Hypokalaemia—Citalopram—alcohol dependence	0.0021	0.00346	CcSEcCtD
Nabumetone—Malaise—Acamprosate—alcohol dependence	0.00209	0.00344	CcSEcCtD
Nabumetone—Vertigo—Acamprosate—alcohol dependence	0.00208	0.00343	CcSEcCtD
Nabumetone—Syncope—Acamprosate—alcohol dependence	0.00208	0.00342	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00208	0.00342	CcSEcCtD
Nabumetone—Leukopenia—Acamprosate—alcohol dependence	0.00208	0.00341	CcSEcCtD
Nabumetone—Tremor—Naltrexone—alcohol dependence	0.00206	0.00338	CcSEcCtD
Nabumetone—Palpitations—Acamprosate—alcohol dependence	0.00205	0.00337	CcSEcCtD
Nabumetone—Gastritis—Citalopram—alcohol dependence	0.00204	0.00336	CcSEcCtD
Nabumetone—Loss of consciousness—Acamprosate—alcohol dependence	0.00204	0.00335	CcSEcCtD
Nabumetone—Ill-defined disorder—Naltrexone—alcohol dependence	0.00204	0.00335	CcSEcCtD
Nabumetone—Cough—Acamprosate—alcohol dependence	0.00202	0.00333	CcSEcCtD
Nabumetone—CYP1A2—digestive system—alcohol dependence	0.00202	0.0198	CbGeAlD
Nabumetone—PTGS2—cardiovascular system—alcohol dependence	0.00202	0.0197	CbGeAlD
Nabumetone—Agitation—Naltrexone—alcohol dependence	0.00202	0.00332	CcSEcCtD
Nabumetone—Angioedema—Naltrexone—alcohol dependence	0.00201	0.0033	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.002	0.0128	CbGpPWpGaD
Nabumetone—Hypertension—Acamprosate—alcohol dependence	0.002	0.00329	CcSEcCtD
Nabumetone—Dysphagia—Citalopram—alcohol dependence	0.002	0.00328	CcSEcCtD
Nabumetone—Asthma—Citalopram—alcohol dependence	0.002	0.00328	CcSEcCtD
Nabumetone—Malaise—Naltrexone—alcohol dependence	0.00198	0.00325	CcSEcCtD
Nabumetone—Syncope—Naltrexone—alcohol dependence	0.00197	0.00324	CcSEcCtD
Nabumetone—Anxiety—Acamprosate—alcohol dependence	0.00197	0.00324	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—ADH1A—alcohol dependence	0.00196	0.0125	CbGpPWpGaD
Nabumetone—PTGS2—pancreas—alcohol dependence	0.00196	0.0192	CbGeAlD
Nabumetone—Pancreatitis—Citalopram—alcohol dependence	0.00196	0.00322	CcSEcCtD
Nabumetone—Discomfort—Acamprosate—alcohol dependence	0.00195	0.00321	CcSEcCtD
Nabumetone—Sweating increased—Citalopram—alcohol dependence	0.00194	0.0032	CcSEcCtD
Nabumetone—Angina pectoris—Citalopram—alcohol dependence	0.00194	0.0032	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00194	0.0124	CbGpPWpGaD
Nabumetone—Palpitations—Naltrexone—alcohol dependence	0.00194	0.00319	CcSEcCtD
Nabumetone—Dry mouth—Acamprosate—alcohol dependence	0.00193	0.00318	CcSEcCtD
Nabumetone—Loss of consciousness—Naltrexone—alcohol dependence	0.00193	0.00317	CcSEcCtD
Nabumetone—CYP1A2—blood—alcohol dependence	0.00193	0.0188	CbGeAlD
Nabumetone—Cough—Naltrexone—alcohol dependence	0.00192	0.00315	CcSEcCtD
Nabumetone—Confusional state—Acamprosate—alcohol dependence	0.00191	0.00314	CcSEcCtD
Nabumetone—Hypertension—Naltrexone—alcohol dependence	0.00189	0.00312	CcSEcCtD
Nabumetone—Anaphylactic shock—Acamprosate—alcohol dependence	0.00189	0.00311	CcSEcCtD
Nabumetone—Dysuria—Citalopram—alcohol dependence	0.00187	0.00307	CcSEcCtD
Nabumetone—Shock—Acamprosate—alcohol dependence	0.00186	0.00306	CcSEcCtD
Nabumetone—Anxiety—Naltrexone—alcohol dependence	0.00186	0.00306	CcSEcCtD
Nabumetone—Thrombocytopenia—Acamprosate—alcohol dependence	0.00185	0.00305	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00185	0.0118	CbGpPWpGaD
Nabumetone—Discomfort—Naltrexone—alcohol dependence	0.00185	0.00304	CcSEcCtD
Nabumetone—Erectile dysfunction—Citalopram—alcohol dependence	0.00184	0.00302	CcSEcCtD
Nabumetone—Hyperhidrosis—Acamprosate—alcohol dependence	0.00183	0.00301	CcSEcCtD
Nabumetone—Dry mouth—Naltrexone—alcohol dependence	0.00183	0.003	CcSEcCtD
Nabumetone—Photosensitivity reaction—Citalopram—alcohol dependence	0.00182	0.003	CcSEcCtD
Nabumetone—Weight increased—Citalopram—alcohol dependence	0.00182	0.00299	CcSEcCtD
Nabumetone—Confusional state—Naltrexone—alcohol dependence	0.00181	0.00297	CcSEcCtD
Nabumetone—Weight decreased—Citalopram—alcohol dependence	0.00181	0.00297	CcSEcCtD
Nabumetone—Anorexia—Acamprosate—alcohol dependence	0.0018	0.00297	CcSEcCtD
Nabumetone—Hyperglycaemia—Citalopram—alcohol dependence	0.0018	0.00296	CcSEcCtD
Nabumetone—Anaphylactic shock—Naltrexone—alcohol dependence	0.00179	0.00295	CcSEcCtD
Nabumetone—Oedema—Naltrexone—alcohol dependence	0.00179	0.00295	CcSEcCtD
Nabumetone—Pneumonia—Citalopram—alcohol dependence	0.00179	0.00294	CcSEcCtD
Nabumetone—Depression—Citalopram—alcohol dependence	0.00177	0.00292	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00176	0.0029	CcSEcCtD
Nabumetone—Shock—Naltrexone—alcohol dependence	0.00176	0.0029	CcSEcCtD
Nabumetone—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.00176	0.0112	CbGpPWpGaD
Nabumetone—Acute coronary syndrome—Citalopram—alcohol dependence	0.00175	0.00288	CcSEcCtD
Nabumetone—PTGS1—digestive system—alcohol dependence	0.00175	0.0171	CbGeAlD
Nabumetone—Myocardial infarction—Citalopram—alcohol dependence	0.00174	0.00287	CcSEcCtD
Nabumetone—Jaundice—Citalopram—alcohol dependence	0.00173	0.00285	CcSEcCtD
Nabumetone—Stomatitis—Citalopram—alcohol dependence	0.00173	0.00285	CcSEcCtD
Nabumetone—Hyperhidrosis—Naltrexone—alcohol dependence	0.00173	0.00285	CcSEcCtD
Nabumetone—PTGS1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00173	0.011	CbGpPWpGaD
Nabumetone—Insomnia—Acamprosate—alcohol dependence	0.00171	0.00282	CcSEcCtD
Nabumetone—Anorexia—Naltrexone—alcohol dependence	0.00171	0.00281	CcSEcCtD
Nabumetone—Paraesthesia—Acamprosate—alcohol dependence	0.0017	0.0028	CcSEcCtD
Nabumetone—Haematuria—Citalopram—alcohol dependence	0.0017	0.00279	CcSEcCtD
Nabumetone—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00169	0.0108	CbGpPWpGaD
Nabumetone—Dyspnoea—Acamprosate—alcohol dependence	0.00169	0.00278	CcSEcCtD
Nabumetone—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00169	0.0108	CbGpPWpGaD
Nabumetone—Somnolence—Acamprosate—alcohol dependence	0.00168	0.00277	CcSEcCtD
Nabumetone—PTGS2—digestive system—alcohol dependence	0.00168	0.0164	CbGeAlD
Nabumetone—CYP1A2—endocrine gland—alcohol dependence	0.00167	0.0163	CbGeAlD
Nabumetone—PTGS1—Biological oxidations—ADH4—alcohol dependence	0.00167	0.0107	CbGpPWpGaD
Nabumetone—PTGS1—blood—alcohol dependence	0.00167	0.0163	CbGeAlD
Nabumetone—Dyspepsia—Acamprosate—alcohol dependence	0.00167	0.00274	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00166	0.0106	CbGpPWpGaD
Nabumetone—Agranulocytosis—Citalopram—alcohol dependence	0.00166	0.00273	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00165	0.0105	CbGpPWpGaD
Nabumetone—Decreased appetite—Acamprosate—alcohol dependence	0.00165	0.00271	CcSEcCtD
Nabumetone—Insomnia—Naltrexone—alcohol dependence	0.00162	0.00266	CcSEcCtD
Nabumetone—Constipation—Acamprosate—alcohol dependence	0.00162	0.00266	CcSEcCtD
Nabumetone—Paraesthesia—Naltrexone—alcohol dependence	0.00161	0.00264	CcSEcCtD
Nabumetone—Haemoglobin—Citalopram—alcohol dependence	0.00161	0.00264	CcSEcCtD
Nabumetone—Haemorrhage—Citalopram—alcohol dependence	0.0016	0.00263	CcSEcCtD
Nabumetone—Dyspnoea—Naltrexone—alcohol dependence	0.0016	0.00263	CcSEcCtD
Nabumetone—PTGS2—blood—alcohol dependence	0.0016	0.0156	CbGeAlD
Nabumetone—Somnolence—Naltrexone—alcohol dependence	0.00159	0.00262	CcSEcCtD
Nabumetone—PTGS2—midbrain—alcohol dependence	0.00158	0.0154	CbGeAlD
Nabumetone—Feeling abnormal—Acamprosate—alcohol dependence	0.00156	0.00257	CcSEcCtD
Nabumetone—Decreased appetite—Naltrexone—alcohol dependence	0.00156	0.00256	CcSEcCtD
Nabumetone—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00155	0.00255	CcSEcCtD
Nabumetone—Fatigue—Naltrexone—alcohol dependence	0.00154	0.00254	CcSEcCtD
Nabumetone—Visual impairment—Citalopram—alcohol dependence	0.00154	0.00253	CcSEcCtD
Nabumetone—Constipation—Naltrexone—alcohol dependence	0.00153	0.00252	CcSEcCtD
Nabumetone—Erythema multiforme—Citalopram—alcohol dependence	0.00151	0.00248	CcSEcCtD
Nabumetone—CYP1A2—liver—alcohol dependence	0.00151	0.0147	CbGeAlD
Nabumetone—Urticaria—Acamprosate—alcohol dependence	0.0015	0.00247	CcSEcCtD
Nabumetone—Abdominal pain—Acamprosate—alcohol dependence	0.0015	0.00246	CcSEcCtD
Nabumetone—Body temperature increased—Acamprosate—alcohol dependence	0.0015	0.00246	CcSEcCtD
Nabumetone—Tinnitus—Citalopram—alcohol dependence	0.00149	0.00245	CcSEcCtD
Nabumetone—Feeling abnormal—Naltrexone—alcohol dependence	0.00148	0.00243	CcSEcCtD
Nabumetone—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00146	0.00241	CcSEcCtD
Nabumetone—PTGS1—endocrine gland—alcohol dependence	0.00145	0.0142	CbGeAlD
Nabumetone—Chills—Citalopram—alcohol dependence	0.00143	0.00236	CcSEcCtD
Nabumetone—Arrhythmia—Citalopram—alcohol dependence	0.00143	0.00235	CcSEcCtD
Nabumetone—Urticaria—Naltrexone—alcohol dependence	0.00142	0.00234	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—ADH7—alcohol dependence	0.00142	0.00906	CbGpPWpGaD
Nabumetone—Abdominal pain—Naltrexone—alcohol dependence	0.00142	0.00233	CcSEcCtD
Nabumetone—Body temperature increased—Naltrexone—alcohol dependence	0.00142	0.00233	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00141	0.00901	CbGpPWpGaD
Nabumetone—Alopecia—Citalopram—alcohol dependence	0.00141	0.00232	CcSEcCtD
Nabumetone—Hypersensitivity—Acamprosate—alcohol dependence	0.00139	0.00229	CcSEcCtD
Nabumetone—PTGS2—endocrine gland—alcohol dependence	0.00138	0.0135	CbGeAlD
Nabumetone—PTGS1—testis—alcohol dependence	0.00138	0.0135	CbGeAlD
Nabumetone—PTGS2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00137	0.00877	CbGpPWpGaD
Nabumetone—Flatulence—Citalopram—alcohol dependence	0.00137	0.00225	CcSEcCtD
Nabumetone—Tension—Citalopram—alcohol dependence	0.00136	0.00224	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—GGT2—alcohol dependence	0.00136	0.00869	CbGpPWpGaD
Nabumetone—Asthenia—Acamprosate—alcohol dependence	0.00136	0.00223	CcSEcCtD
Nabumetone—PTGS1—nervous system—alcohol dependence	0.00136	0.0132	CbGeAlD
Nabumetone—Nervousness—Citalopram—alcohol dependence	0.00135	0.00222	CcSEcCtD
Nabumetone—Pruritus—Acamprosate—alcohol dependence	0.00134	0.0022	CcSEcCtD
Nabumetone—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.00133	0.0085	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00132	0.00843	CbGpPWpGaD
Nabumetone—Hypersensitivity—Naltrexone—alcohol dependence	0.00132	0.00217	CcSEcCtD
Nabumetone—PTGS1—central nervous system—alcohol dependence	0.00131	0.0128	CbGeAlD
Nabumetone—Tremor—Citalopram—alcohol dependence	0.0013	0.00214	CcSEcCtD
Nabumetone—PTGS2—nervous system—alcohol dependence	0.0013	0.0127	CbGeAlD
Nabumetone—Diarrhoea—Acamprosate—alcohol dependence	0.0013	0.00213	CcSEcCtD
Nabumetone—Ill-defined disorder—Citalopram—alcohol dependence	0.00129	0.00212	CcSEcCtD
Nabumetone—Anaemia—Citalopram—alcohol dependence	0.00129	0.00211	CcSEcCtD
Nabumetone—Asthenia—Naltrexone—alcohol dependence	0.00129	0.00211	CcSEcCtD
Nabumetone—Agitation—Citalopram—alcohol dependence	0.00128	0.0021	CcSEcCtD
Nabumetone—Angioedema—Citalopram—alcohol dependence	0.00127	0.00209	CcSEcCtD
Nabumetone—Pruritus—Naltrexone—alcohol dependence	0.00127	0.00208	CcSEcCtD
Nabumetone—Malaise—Citalopram—alcohol dependence	0.00125	0.00206	CcSEcCtD
Nabumetone—Dizziness—Acamprosate—alcohol dependence	0.00125	0.00206	CcSEcCtD
Nabumetone—Vertigo—Citalopram—alcohol dependence	0.00125	0.00205	CcSEcCtD
Nabumetone—PTGS2—liver—alcohol dependence	0.00125	0.0122	CbGeAlD
Nabumetone—PTGS2—central nervous system—alcohol dependence	0.00125	0.0122	CbGeAlD
Nabumetone—Syncope—Citalopram—alcohol dependence	0.00125	0.00205	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—ADH1B—alcohol dependence	0.00125	0.00795	CbGpPWpGaD
Nabumetone—Leukopenia—Citalopram—alcohol dependence	0.00124	0.00205	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—PDYN—alcohol dependence	0.00124	0.00793	CbGpPWpGaD
Nabumetone—Palpitations—Citalopram—alcohol dependence	0.00123	0.00202	CcSEcCtD
Nabumetone—Diarrhoea—Naltrexone—alcohol dependence	0.00123	0.00202	CcSEcCtD
Nabumetone—Loss of consciousness—Citalopram—alcohol dependence	0.00122	0.00201	CcSEcCtD
Nabumetone—PTGS2—cerebellum—alcohol dependence	0.00122	0.0119	CbGeAlD
Nabumetone—Cough—Citalopram—alcohol dependence	0.00121	0.002	CcSEcCtD
Nabumetone—Vomiting—Acamprosate—alcohol dependence	0.0012	0.00198	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.0012	0.00766	CbGpPWpGaD
Nabumetone—Hypertension—Citalopram—alcohol dependence	0.0012	0.00197	CcSEcCtD
Nabumetone—Rash—Acamprosate—alcohol dependence	0.00119	0.00196	CcSEcCtD
Nabumetone—Dermatitis—Acamprosate—alcohol dependence	0.00119	0.00196	CcSEcCtD
Nabumetone—Headache—Acamprosate—alcohol dependence	0.00119	0.00195	CcSEcCtD
Nabumetone—Dizziness—Naltrexone—alcohol dependence	0.00118	0.00195	CcSEcCtD
Nabumetone—Anxiety—Citalopram—alcohol dependence	0.00118	0.00194	CcSEcCtD
Nabumetone—Discomfort—Citalopram—alcohol dependence	0.00117	0.00192	CcSEcCtD
Nabumetone—Dry mouth—Citalopram—alcohol dependence	0.00116	0.0019	CcSEcCtD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00115	0.00736	CbGpPWpGaD
Nabumetone—Confusional state—Citalopram—alcohol dependence	0.00114	0.00188	CcSEcCtD
Nabumetone—Vomiting—Naltrexone—alcohol dependence	0.00114	0.00187	CcSEcCtD
Nabumetone—Oedema—Citalopram—alcohol dependence	0.00113	0.00187	CcSEcCtD
Nabumetone—Anaphylactic shock—Citalopram—alcohol dependence	0.00113	0.00187	CcSEcCtD
Nabumetone—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.00113	0.00722	CbGpPWpGaD
Nabumetone—Rash—Naltrexone—alcohol dependence	0.00113	0.00186	CcSEcCtD
Nabumetone—Dermatitis—Naltrexone—alcohol dependence	0.00113	0.00186	CcSEcCtD
Nabumetone—Nausea—Acamprosate—alcohol dependence	0.00112	0.00185	CcSEcCtD
Nabumetone—Headache—Naltrexone—alcohol dependence	0.00112	0.00185	CcSEcCtD
Nabumetone—Shock—Citalopram—alcohol dependence	0.00112	0.00184	CcSEcCtD
Nabumetone—Thrombocytopenia—Citalopram—alcohol dependence	0.00111	0.00183	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—GGT1—alcohol dependence	0.0011	0.00702	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Citalopram—alcohol dependence	0.0011	0.0018	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00109	0.00693	CbGpPWpGaD
Nabumetone—Anorexia—Citalopram—alcohol dependence	0.00108	0.00178	CcSEcCtD
Nabumetone—MPO—C-MYB transcription factor network—EP300—alcohol dependence	0.00108	0.0069	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.00108	0.00687	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.00106	0.0068	CbGpPWpGaD
Nabumetone—Nausea—Naltrexone—alcohol dependence	0.00106	0.00175	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00105	0.00672	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.00105	0.00667	CbGpPWpGaD
Nabumetone—PTGS1—brain—alcohol dependence	0.00104	0.0101	CbGeAlD
Nabumetone—PTGS1—Biological oxidations—MAOB—alcohol dependence	0.00103	0.00659	CbGpPWpGaD
Nabumetone—Insomnia—Citalopram—alcohol dependence	0.00103	0.00169	CcSEcCtD
Nabumetone—Paraesthesia—Citalopram—alcohol dependence	0.00102	0.00168	CcSEcCtD
Nabumetone—Dyspnoea—Citalopram—alcohol dependence	0.00101	0.00166	CcSEcCtD
Nabumetone—Somnolence—Citalopram—alcohol dependence	0.00101	0.00166	CcSEcCtD
Nabumetone—Dyspepsia—Citalopram—alcohol dependence	0.000999	0.00164	CcSEcCtD
Nabumetone—PTGS2—brain—alcohol dependence	0.00099	0.00968	CbGeAlD
Nabumetone—Decreased appetite—Citalopram—alcohol dependence	0.000987	0.00162	CcSEcCtD
Nabumetone—Fatigue—Citalopram—alcohol dependence	0.000978	0.00161	CcSEcCtD
Nabumetone—Constipation—Citalopram—alcohol dependence	0.000971	0.0016	CcSEcCtD
Nabumetone—Feeling abnormal—Citalopram—alcohol dependence	0.000935	0.00154	CcSEcCtD
Nabumetone—Gastrointestinal pain—Citalopram—alcohol dependence	0.000928	0.00153	CcSEcCtD
Nabumetone—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000905	0.00578	CbGpPWpGaD
Nabumetone—Urticaria—Citalopram—alcohol dependence	0.000902	0.00148	CcSEcCtD
Nabumetone—Body temperature increased—Citalopram—alcohol dependence	0.000897	0.00148	CcSEcCtD
Nabumetone—Abdominal pain—Citalopram—alcohol dependence	0.000897	0.00148	CcSEcCtD
Nabumetone—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000882	0.00563	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—ALDH2—alcohol dependence	0.000877	0.0056	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000874	0.00558	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000873	0.00557	CbGpPWpGaD
Nabumetone—Hypersensitivity—Citalopram—alcohol dependence	0.000836	0.00137	CcSEcCtD
Nabumetone—Asthenia—Citalopram—alcohol dependence	0.000814	0.00134	CcSEcCtD
Nabumetone—Pruritus—Citalopram—alcohol dependence	0.000803	0.00132	CcSEcCtD
Nabumetone—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000777	0.00496	CbGpPWpGaD
Nabumetone—Diarrhoea—Citalopram—alcohol dependence	0.000777	0.00128	CcSEcCtD
Nabumetone—Dizziness—Citalopram—alcohol dependence	0.000751	0.00123	CcSEcCtD
Nabumetone—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.00075	0.00479	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000742	0.00474	CbGpPWpGaD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000732	0.00467	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000722	0.00461	CbGpPWpGaD
Nabumetone—Vomiting—Citalopram—alcohol dependence	0.000722	0.00119	CcSEcCtD
Nabumetone—Rash—Citalopram—alcohol dependence	0.000716	0.00118	CcSEcCtD
Nabumetone—Dermatitis—Citalopram—alcohol dependence	0.000715	0.00118	CcSEcCtD
Nabumetone—Headache—Citalopram—alcohol dependence	0.000711	0.00117	CcSEcCtD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000707	0.00451	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—CYP2E1—alcohol dependence	0.000701	0.00448	CbGpPWpGaD
Nabumetone—Nausea—Citalopram—alcohol dependence	0.000674	0.00111	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—GGT1—alcohol dependence	0.000644	0.00411	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000638	0.00407	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000612	0.0039	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000593	0.00379	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—MAOA—alcohol dependence	0.000577	0.00368	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000568	0.00363	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000559	0.00357	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000494	0.00316	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000488	0.00311	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000464	0.00296	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADH6—alcohol dependence	0.000405	0.00259	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000394	0.00252	CbGpPWpGaD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000392	0.0025	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—POMC—alcohol dependence	0.000376	0.0024	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—EP300—alcohol dependence	0.000351	0.00224	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADH1A—alcohol dependence	0.000336	0.00214	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADH6—alcohol dependence	0.000322	0.00205	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000322	0.00205	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000322	0.00205	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000318	0.00203	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000315	0.00201	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000311	0.00198	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000289	0.00185	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADH4—alcohol dependence	0.000286	0.00182	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADH1A—alcohol dependence	0.000267	0.0017	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000259	0.00165	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000247	0.00158	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADH7—alcohol dependence	0.000243	0.00155	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GGT2—alcohol dependence	0.000233	0.00149	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADH4—alcohol dependence	0.000227	0.00145	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADH1B—alcohol dependence	0.000213	0.00136	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000196	0.00125	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADH7—alcohol dependence	0.000193	0.00123	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GGT2—alcohol dependence	0.000185	0.00118	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADH6—alcohol dependence	0.000182	0.00116	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000182	0.00116	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MAOB—alcohol dependence	0.000176	0.00113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADH1B—alcohol dependence	0.000169	0.00108	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—POMC—alcohol dependence	0.000169	0.00108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADH1A—alcohol dependence	0.000151	0.000963	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALDH2—alcohol dependence	0.00015	0.000958	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000144	0.000921	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MAOB—alcohol dependence	0.00014	0.000894	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADH4—alcohol dependence	0.000128	0.000819	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GOT2—alcohol dependence	0.000128	0.000814	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GOT2—alcohol dependence	0.000121	0.000772	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2E1—alcohol dependence	0.00012	0.000765	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDH2—alcohol dependence	0.000119	0.00076	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000115	0.000731	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000111	0.000709	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GGT1—alcohol dependence	0.00011	0.000703	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GOT1—alcohol dependence	0.00011	0.000703	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADH7—alcohol dependence	0.000109	0.000696	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GGT2—alcohol dependence	0.000105	0.000668	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GOT1—alcohol dependence	0.000104	0.000666	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GOT2—alcohol dependence	0.000101	0.000646	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MAOA—alcohol dependence	9.87e-05	0.00063	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.57e-05	0.000611	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADH1B—alcohol dependence	9.57e-05	0.000611	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2E1—alcohol dependence	9.52e-05	0.000608	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GGT1—alcohol dependence	8.74e-05	0.000558	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GOT1—alcohol dependence	8.74e-05	0.000558	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MAOB—alcohol dependence	7.93e-05	0.000506	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MAOA—alcohol dependence	7.83e-05	0.0005	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.6e-05	0.000485	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDH2—alcohol dependence	6.74e-05	0.00043	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.48e-05	0.000414	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—POMC—alcohol dependence	6.42e-05	0.00041	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GOT2—alcohol dependence	5.73e-05	0.000366	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2E1—alcohol dependence	5.39e-05	0.000344	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—POMC—alcohol dependence	5.1e-05	0.000326	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GGT1—alcohol dependence	4.95e-05	0.000316	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GOT1—alcohol dependence	4.95e-05	0.000316	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MAOA—alcohol dependence	4.43e-05	0.000283	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.3e-05	0.000274	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—EP300—alcohol dependence	4.26e-05	0.000272	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EP300—alcohol dependence	4.04e-05	0.000258	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—EP300—alcohol dependence	3.38e-05	0.000216	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—POMC—alcohol dependence	2.89e-05	0.000184	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—EP300—alcohol dependence	1.91e-05	0.000122	CbGpPWpGaD
